FCMI
CBAY
Foresite Capital Management III’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.75M | Hold |
1,641,804
| – | – | 15.17% | 4 |
|
|
2022
Q2 | $4.84M | Hold |
1,641,804
| – | – | 17.57% | 3 |
|
|
2022
Q1 | $5.11M | Hold |
1,641,804
| – | – | 15.56% | 4 |
|
|
2021
Q4 | $5.55M | Hold |
1,641,804
| – | – | 14.05% | 4 |
|
|
2021
Q3 | $5.99M | Hold |
1,641,804
| – | – | 8.31% | 4 |
|
|
2021
Q2 | $7.16M | Hold |
1,641,804
| – | – | 7.59% | 7 |
|
|
2021
Q1 | $7.45M | Hold |
1,641,804
| – | – | 6.55% | 7 |
|
|
2020
Q4 | $9.42M | Hold |
1,641,804
| – | – | 10.95% | 7 |
|
|
2020
Q3 | $11.9M | Buy |
1,641,804
+41,846
| +3% | +$303K | 8.85% | 6 |
|
|
2020
Q2 | $5.58M | Buy |
+1,599,958
| New | +$5.58M | 4.97% | 6 |
|
|
2020
Q1 | – | Sell |
-1,504,710
| Closed | -$2.95M | – | 12 |
|
|
2019
Q4 | $2.95M | Sell |
1,504,710
-3,381
| -0.2% | -$6.63K | 1.65% | 9 |
|
|
2019
Q3 | $7.72M | Sell |
1,508,091
-79,010
| -5% | -$405K | 2.95% | 13 |
|
|
2019
Q2 | $11.4M | Hold |
1,587,101
| – | – | 3.73% | 11 |
|
|
2019
Q1 | $21.1M | Hold |
1,587,101
| – | – | 5.49% | 6 |
|
|
2018
Q4 | $12.5M | Buy |
1,587,101
+25,061
| +2% | +$197K | 4.1% | 9 |
|
|
2018
Q3 | $17.3M | Hold |
1,562,040
| – | – | 3.82% | 7 |
|
|
2018
Q2 | $21M | Hold |
1,562,040
| – | – | 4.51% | 7 |
|
|
2018
Q1 | $20.3M | Buy |
1,562,040
+962,040
| +160% | +$12.5M | 4.42% | 8 |
|
|
2017
Q4 | $5.52M | Hold |
600,000
| – | – | 1.55% | 13 |
|
|
2017
Q3 | $4.84M | Buy |
+600,000
| New | +$4.84M | 1.33% | 15 |
|